Cancer Isn’t One Size Fits All: Nashawn’s Story

A patient’s genetic makeup and journey with leukemia highlights the need for more gene sequencing in minority children.

10:28 AM

Author | Jordyn Imhoff

child in hospital with mask on and orange background
Nashawn, 11. Photo: Chris Hedly

First, 9-year-old Nashawn was complaining of heavy arms when swimming at his local recreation center. Soon after that, he had to take breaks walking from his room to the bathroom to take a shower.

Antoinette Howard, Nashawn's mom, made an appointment with his primary care provider at Briarwood. After a quick evaluation his doctor sent him to the emergency room because she wasn't comfortable with how he looked. He was immediately taken back for blood work that showed his hemoglobin, a protein that helps transport oxygen in the blood, was low. In fact, his levels were 2.4 when the normal low is 5. Even more alarming, his white blood cell count was 88,000. A normal range is between 4,000 and 11,000.

"We knew it was something serious when his primary care doctor sent him to the emergency room but we didn't know how serious it was," Howard says. "My husband was trying to keep me from getting too stressed out by making me go to work against my better judgement. He called me and told me what his blood work showed and when I heard the diagnosis, I immediately left to go to the hospital."

In July 2018, the results indicated cancer and a diagnosis of acute lymphoblastic leukemia was made. Treatments would begin, but Nashawn wasn't responding to them. To figure out why, Rajen Mody, M.D., M.S., a pediatric oncologist at C.S. Mott Children's Hospital, did gene sequencing of Nashawn's tumor.

"He presented like any other patient with leukemia, but I quickly realized there might be something else at play because he had a poor early response to treatment," Mody says. "The genetic testing showed Nashawn had high risk cancer gene features."

The features of interest were an unusual genotype: mutations found on two of Nashawn's genes, NRAS and FLT3. This genotype, which affected how he responded to treatment, is a perfect example of why sequencing minority children is critical. Kids like Nashawn may not always get necessary or lifesaving medical treatment early.

There was a 17% chance Nashawn's brother would be a perfect match, and by the grace of God he was.
Antoinette Howard

According to Mody, survival rate for African American children are 15% less than their Caucasian counterpart. Why is that? Is it that minority children, generally, have less access to hospitals with certain cutting edge research technologies? When technology is available, is it being offered to them an equal amount of times its being offered to a Caucasian child? Is there an adverse biological component?

It's difficult to figure out why the survival rate is lower when minority gene samples make up such a small proportion of the sequencing pool. "In pediatric cancer, only 8-10% of the gene sequencing pool is made up of minority samples," Mody says. "These numbers should be closer to 30-40%."

These alarming statistics inspired Mody to design a multi-institutional project that is sequencing a multi-ethnic cohort of pediatric cancer patients like Nashawn from Ann Arbor, Detroit and Flint.

"A cancer diagnosis on its own is overwhelming for a family so you don't want any other factors to work against them and their child's medical journey," Mody says. "Every child deserves the best fighting chance, and it may start with gene sequencing."

MORE FROM MICHIGAN: Sign up for our weekly newsletter

A perfect match

The nine months after Nashawn's diagnosis were a whirlwind. He started with chemotherapy infusion treatments three times a week. The hope was that over time, the treatments could be reduced to twice a week, once a week, every other week and so on. Part of his treatment plan, like shots in the arm, could be done at home. Nashawn spent a lot of time inpatient for treatments along with an allergic reaction to the chemotherapy that he was admitted for.

The road to recovery, like any medical journey, can feel like a rollercoaster ride. Luckily, Nashawn was responding to treatments and nearing the end of nine months, Howard and the care team discussed a bone marrow transplant.

Nashawn and Gregory Yanik, M.D., pediatric hematologist and oncologist. ( Chris Hedly)

"There was a 17% chance Nashawn's brother would be a perfect match, and by the grace of God he was," Howard says. The transplant took place in April 2019.

"When you discuss worst case scenarios, you expect it and can prepare as much as possible" Howard says. "But post-transplant, he was doing great. Instead of his numbers fluctuating as expected they just kept going up."

He was released from the hospital five days after the transplant. Now, Nashawn is 11-years-old and is doing well in the "maintenance" phase of his treatment plan. He even started sixth grade online this fall.

With a $592,100 grant from the Children's Hospital of Michigan Foundation for Mody's project and support from Michigan Medicine and the Chad Carr Pediatric Brain Tumor Center, other minority children may have an outcome like Nashawn's more often.

"Nashawn's case is incredible," Mody says. "It's because of kids like him that studying genetic and socioeconomic differences that may contribute to cancer outcomes is critical. These factors will lay the groundwork for creating the best treatment plans for different populations."

Visit the C.S. Mott Children's Hospital's website for more information about genetic testing and genomic medicine.


More Articles About: Children's Health Leukemia Cancer and Genetics Cancer Diagnosis Cancer Testing Chemotherapy Cancer Treatment Community Health Race and Ethnicity Genetic Testing Health Care Delivery, Policy and Economics CS Mott Children's Hospital Bone Marrow Transplant (BMT) Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories mom and child with pacificer and older teen with pacifier in his mouth on other side of blue bench
Health Lab
Are parents waiting too long to stop pacifier use or thumb-sucking in kids?
A national poll looks at how parents tackle thumb-sucking and pacifier use —two habits that can benefit children but that can also be challenging to stop.
girl hugging teddy bear with alcohol bottles on ground
Health Lab
1 in 4 kids live with parents who have alcohol or other drug problems
Children living with parents who have addiction issues, also called substance used disorder, have higher risks later in life. A new study shows 1 in 4 currently live in such households.
2025 blocks with stethoscope
Health Lab
Top 10 things to know about your health costs right now
From Medicare prescription costs and medical debt rules to actions that the Supreme Court, Congress and President Trump have taken or could take, a guide to health policies that affect many people.
american flag with stethoscope on it
Health Lab
What does Medicaid do?
Medicaid provides health insurance coverage for tens of millions of American children and adults. Research on its impact shows positive effects in many ways.
family photo mom dad and four kids in soft white beige and black clothes outside in field with trees behind
Health Lab
After life threatening pregnancy complication, mom of 4 embraces little moments
A rare pregnancy complication, known as placenta accreta, put both a mom and her baby at risk.
red cells stacked ontop of darker red background
Health Lab
Medicaid unwinding linked to opioid addiction treatment disruptions
Buprenorphine prescription interruptions were most common in states that had the biggest coverage drops during Medicaid unwinding; study has importance for future Medicaid policy.